Wednesday, February 1, 2017

BRIEF-Biotec Pharmacon Q4 EBITDA loss widens to NOK 8.1 mln

* Q4 revenue 18.2 million Norwegian crowns ($2.2

million)versus 13.1 million crowns year ago

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)